0001104659-23-009908.txt : 20230202 0001104659-23-009908.hdr.sgml : 20230202 20230202161717 ACCESSION NUMBER: 0001104659-23-009908 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230131 FILED AS OF DATE: 20230202 DATE AS OF CHANGE: 20230202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kirschbaum Mark CENTRAL INDEX KEY: 0001830211 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50626 FILM NUMBER: 23581137 MAIL ADDRESS: STREET 1: 66 WEST 38TH STREET, APT. 19D CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclacel Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001130166 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911766850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-7330 MAIL ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 FORMER COMPANY: FORMER CONFORMED NAME: XCYTE THERAPIES INC DATE OF NAME CHANGE: 20001218 4 1 tm235262-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2023-01-31 0 0001130166 Cyclacel Pharmaceuticals, Inc. CYCC 0001830211 Kirschbaum Mark C/O CYCLACEL PHARMACEUTICALS, INC., 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ 07922 0 1 0 0 Chief Medical Officer Common Stock 2023-01-31 4 A 0 31200 0 A 31200 D The reporting person received an award of 31,200 restricted stock units on January 31, 2023, which shall vest in full on January 31, 2026, provided, however, that if certain clinical milestones are achieved then such restricted stock units shall vest in full earlier in connection with such achievement. /s/ Mark Kirschbaum 2023-02-02